LightDeck Diagnostics
Biotechnology ResearchColorado, United States51-200 Employees
LightDeck Diagnostics, based in Boulder, Colorado, operates in the biotechnology research sector. The company offers a portable diagnostic platform designed to deliver lab-quality results rapidly at the point of care, with a straightforward workflow and low per-test cost. The platform comprises a compact analyzer and disposable, multiplex test cartridges that enable several related tests to be performed together, with internal quality controls for reliability. The initial on-the-spot test targets COVID-19, and the platform is already commercialized for veterinary diagnostics and environmental testing. From its MBio Diagnostics roots, LightDeck Diagnostics has evolved through corporate moves, including a 2020 merger with BravaDx and a 2023 acquisition by Heska Corporation. Its diagnostics address needs in veterinary medicine and environmental testing, providing rapid, quantitative results to inform clinical or risk-management decisions. The company fits within the biotechnology research industry, emphasizing point-of-care capabilities that extend testing beyond traditional laboratories. The organization operates as a mid-sized enterprise centered in Boulder.